MedAvail to Present at the 39th Annual J.P. Morgan Healthcare Conference
MedAvail Holdings, Inc. (Nasdaq: MDVL) recently announced its participation in the 39th Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled retail pharmacy company driving best in class medication adherence by embedding its pharmacy services directly into Medicare focused clinics using its proprietary MedCenter solution, today announced that the company will be participating in the upcoming 39th Annual J.P. Morgan Healthcare Conference.
MedAvail’s management is scheduled to present on Thursday, January 14, 2021 at 3:40 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at https://investors.medavail.com/.
About MedAvail
MedAvail Holdings Inc. (NASDAQ: MDVL) is a technology-enabled pharmacy organization, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes. Learn more at www.medavail.com.
SOURCE MedAvail Holdings Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210106005181/en/